DOI QR코드

DOI QR Code

Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer

  • Yaylaci, Selcuk (Department of Internal Medicine, Sakarya University) ;
  • Tosun, Onder (Department of General Surgery, Findikli Goiter Research and Treatment Center, Sakarya University) ;
  • Sahin, Orhan (Department of General Surgery, Findikli Goiter Research and Treatment Center, Sakarya University) ;
  • Genc, Ahmet Bilal (Department of Internal Medicine, Medical Faculty, Sakarya University) ;
  • Aydin, Ercan (Department of Cardiology, Vakfikebir State Hospital) ;
  • Demiral, Gokhan (Department of General Surgery, Rize State Hospital) ;
  • Karahalil, Fatma (Department of Chemistry, Faculty of Arts and Sciences, Karadeniz Technical University) ;
  • Olt, Serdar (Department of Internal Medicine, Medical Faculty, Sakarya University) ;
  • Ergenc, Hasan (Department of Internal Medicine, Medical Faculty, Sakarya University) ;
  • Varim, Ceyhun (Department of Internal Medicine, Medical Faculty, Sakarya University)
  • 발행 : 2016.06.01

초록

Background: Inflammatory hematological parameters like the neutrophil/lymphocyte (N/L) ratio have been investigated in many cancer types and significant relationships found with prognosis, for example. The aim of this present study was to investigate the impact of hematological parameters notably on N/L ratio and mean platelet volume (MPV) in papillary thyroid cancer cases. Materials and Methods: A total of 79 patients who underwent a thyroidectomy operation in Findikli, Goiter Research and Treatment Center during 2011-2015 period were enrolled in the study, 41 with papillary thyroid cancer and 38 with benign goiter confirmed by pathological examination. We collected clinical and laboratory data for the patients from hospital records retrospectively. Blood samples taken at admission were assessed for parameters compared between the groups. Results: No significant differences between papillary thyroid cancer and benign goiter groups were apparent in terms of age, the N/L ratio, MPV, white blood cell count (WBC), red blood cell count (RBC), hemoglobin, hematocrit, platelet, neutrophil, lymphocyte, red blood cell distribution width (RDW) and platelet crit (PCT) levels (p>0.05). Only the level of platelet distribution width (PDW) significantly differed, being lower in the papillary cancer group (p<0.05). Conclusions: No significant relationship between papillary thyroid cancer and inflammatory hematological parameters including in particular the N/L ratio and MPV. The relevance of the PDW values remains unclear.

키워드

참고문헌

  1. Absenger G, Szkandera J, Stotz M, et al (2013). Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Anticancer Res, 33, 4591-4.
  2. Baldane S, Ipekci SH, Sozen M, et al (2015). Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas. Asian Pac J Cancer Prev, 16, 2671-4. https://doi.org/10.7314/APJCP.2015.16.7.2671
  3. Eryilmaz A, Basal Y, OmurluI K (2015). Can head and neck cancers be detected with mean platelet volume? Asian Pac J Cancer Prev, 16, 7045-7. https://doi.org/10.7314/APJCP.2015.16.16.7045
  4. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al (2011). Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des, 17, 47-58. https://doi.org/10.2174/138161211795049804
  5. Guthrie GJ, Charles KA, Roxburgh CS, et al (2013). The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol, 88, 218-30. https://doi.org/10.1016/j.critrevonc.2013.03.010
  6. Haugen BR, Alexander EK, Bible KC, et al (2016). American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26, 1-133. https://doi.org/10.1089/thy.2015.0020
  7. Hegedus L (2004). Clinical practice. The thyroid nodule. N Engl J Med, 351, 1764-71. https://doi.org/10.1056/NEJMcp031436
  8. Karateke A, Kaplanoglu M, Baloglu A (2015). Relations of Platelet Indices with Endometrial Hyperplasia and Endometrial Cancer. Asian Pac J Cancer Prev, 16, 4905-8. https://doi.org/10.7314/APJCP.2015.16.12.4905
  9. Kemal Y, Yucel I, Ekiz K, et al (2014). Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev, 15, 2651-4. https://doi.org/10.7314/APJCP.2014.15.6.2651
  10. Kilincalp S, Ekiz F, Başar O, et al (2014). Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets, 25, 592-4. https://doi.org/10.3109/09537104.2013.783689
  11. Kim JH, Han DS, Bang HY, et al (2015). Preoperative neutrophilto- lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer. Ann Surg Treat Res, 89, 81-6. https://doi.org/10.4174/astr.2015.89.2.81
  12. Kocer D, Karakukcu C, Karaman H, et al (2015). May the neutrophil/ lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev, 16, 3875-9. https://doi.org/10.7314/APJCP.2015.16.9.3875
  13. Kumagai S, Tokuno J, Ueda Y, et al (2015). Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer. Mol Clin Oncol, 3, 197-201. https://doi.org/10.3892/mco.2014.436
  14. Kurtoglu E, Kokcu A, Celik H, et al (2015). Platelet indices may be useful in discrimination of benign and malign endometrial lesions, and early and advanced stage endometrial cancer. Asian Pac J Cancer Prev, 16, 5397-400. https://doi.org/10.7314/APJCP.2015.16.13.5397
  15. Li JY, Li Y, Jiang Z, et al (2014). Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev, 15, 10501-4.
  16. Mandel SJ (2004). A 64-year-old woman with a thyroid nodule. JAMA, 292, 2632-42. https://doi.org/10.1001/jama.292.21.2632
  17. Olt S (2015). Relationship between thyroid nodules and neutrophil/lymphocyte ratio. Acta Medica Mediterranea, 31, 725-7.
  18. Seretis C, Gourgiotis S, Gemenetzis G, et al (2013). The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg, 205, 691-6. https://doi.org/10.1016/j.amjsurg.2012.08.006
  19. Sherman SI (2003). Thyroid carcinoma. Lancet, 361,501-511. https://doi.org/10.1016/S0140-6736(03)12488-9
  20. Tunbridge WM, Evered DC, Hall R, et al (1977). The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol, 7, 481-93. https://doi.org/10.1111/j.1365-2265.1977.tb01340.x
  21. Vander JB, Gaston EA, Dawber TR et al (1968). The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med, 69, 537-40. https://doi.org/10.7326/0003-4819-69-3-537

피인용 문헌

  1. Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma vol.2017, pp.1687-8345, 2017, https://doi.org/10.1155/2017/8471235
  2. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions vol.42, pp.4, 2017, https://doi.org/10.1080/07435800.2017.1319859
  3. Platelet distribution width correlates with prognosis of non-small cell lung cancer vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-03772-z
  4. Evaluation of Hemocytometer Parameters as Potential Biomarkers in Benign Multinodular Goiter and Papillary Thyroid Carcinoma vol.19, pp.12, 2017, https://doi.org/10.5812/ircmj.58295
  5. Diagnostic Accuracy of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Detecting Occult Papillary Thyroid Microcarcinomas in Benign Multinodular Goitres vol.2018, pp.2042-0072, 2018, https://doi.org/10.1155/2018/3470429
  6. Different prognostic values of individual hematologic parameters in papillary thyroid cancer due to age-related changes in immunity vol.96, pp.2, 2019, https://doi.org/10.4174/astr.2019.96.2.70